CCO Secures Strategic Manufacturing Partnership
Released
Released
Announcement PDF
The Calmer Co International Limited
24 Cansdale St, Yeronga Queensland 4104
ACN: 169 441 874
Doc 1418089494.1
July 30 2026 ASX RELEASE
The Calmer Co. Secures Strategic
Manufacturing Partnership to Scale Global
Kava, Ginger and Turmeric Extract Production
Long-term partnership with Kaiming Agro Processing combines
advanced manufacturing with The Calmer Co.'s brands,
innovation and global commercialisation capabilities
Brisbane, Australia – The Calmer Co. International Limited (ASX: CCO), a leading
consumer packaged goods company specialising in kava and other natural products that
promote relaxation and sleep support, is pleased to announce that it has entered into a
Binding Strategic Partnership Heads of Agreement (“HOA”) with Kaiming Agro Processing
Pte Ltd’s Subsidiary Pacific Culture and Heritage Pte. Ltd (“KAPPL”).
The HOA establishes the framework for negotiating definitive agreements for a long-term
strategic partnership that combines KAPPL's investment in advanced botanical
manufacturing capability with The Calmer Co.'s expertise in premium raw material
sourcing, internationally recognised brands, proprietary formulations, product innovation
and global commercialisation.
The Partnership is intended to support The Calmer Co.'s strategy of expanding its premium
botanical ingredients business while continuing to grow its branded consumer products
portfolio through a scalable and capital-efficient operating model. The Partnership aligns
advanced manufacturing capability with The Calmer Co.'s growing international premium
botanical ingredients business, enabling greater value-added processing within Fiji while
preserving the Company's existing global manufacturing relationships.
Importantly, the Partnership preserves The Calmer Co.'s core competitive strengths. The
Company will continue to control the procurement of premium kava raw materials,
proprietary formulations, product specifications, intellectual property, internationally
recognised brands and global customer relationships, while KAPPL will provide advanced
manufacturing capability for agreed branded consumer products and premium botanical
ingredients.
The Board believes the Partnership represents an important strategic milestone in the
Company's evolution, strengthening its manufacturing capability, expanding its premium
botanical ingredients platform and creating a framework for long-term strategic
collaboration.
Doc 1418089494.1 2
Strategic Highlights
• Binding Strategic Partnership Heads of Agreement executed with Kaiming Agro
Processing Pte Ltd.
• Establishes a framework to negotiate definitive agreements for long-term strategic
manufacturing partnership supporting The Calmer Co.'s premium botanical
ingredients and branded consumer products businesses.
• KAPPL to become The Calmer Co.'s preferred manufacturing partner for agreed Fiji-
manufactured products, subject to execution of definitive agreements.
• The Calmer Co. appointed exclusive global commercialisation partner for agreed
kava, ginger and turmeric CO2 extract products manufactured by KAPPL, subject to
The Calmer Co. continuing to actively develop and commercialise these products
internationally.
• The Calmer Co. retains ownership and control of premium raw material
procurement, proprietary formulations, intellectual property, Fiji Kava®
, Taki Mai®
and Authentic Kava®
brands, customer relationships and global commercialisation.
• KAPPL is currently constructing an advanced manufacturing facility in Navua, Fiji,
incorporating supercritical CO₂ extraction capability, with commissioning expected
in December 2026.
• The Partnership expands The Calmer Co.'s manufacturing capability by adding
advanced extraction capability within Fiji while complementing the Company's
existing specialist extraction partners in Australia and India.
• The Partnership supports continued growth across premium botanical ingredients,
branded consumer products, private label manufacturing and contract
manufacturing opportunities.
• The HOA establishes a three-phase strategic partnership framework providing a
pathway for progressive collaboration as commercial milestones are achieved.
Strategic Rationale
The Partnership has been established at an important point in the development of both
organisations.
KAPPL has established itself as one of Fiji's leading producers and exporters of value-
added botanical products, supplying customers across Australia, New Zealand, North
America, the United Kingdom and Europe. The company is now investing in a new
advanced botanical manufacturing facility in Navua, Fiji, incorporating supercritical CO₂
extraction capability together with expanded processing infrastructure. Once
commissioned, the facility is expected to become one of Fiji's most advanced botanical
processing facilities, capable of manufacturing premium botanical ingredients and value-
added consumer products for international markets.
Doc 1418089494.1 3
Over many years, The Calmer Co. has invested significantly in research and development,
proprietary formulations, premium raw material supply chains, extraction technologies,
regulatory capability, internationally recognised brands and global customer relationships.
These investments have already resulted in commercial opportunities across ingredient
supply, branded consumer products and international customer partnerships, creating a
growing requirement for additional advanced manufacturing capability to support future
growth.
Recognising these complementary strengths, the Parties have agreed that a long-term
strategic partnership represents the most effective pathway to accelerate future growth.
Independent market research indicates continued global growth in demand for value-
added botanical extracts across the categories relevant to the Partnership. Future Market
Insights estimates the global turmeric market will grow from approximately US$4.9 billion
in 2025 to US$8.4 billion by 2035 (a 5.5% compound annual growth rate), with food and
beverage processing representing the largest end-use segment. Market Research Future
estimates the global ginger extract market growing from approximately US$1.36 billion in
2025 to US$2.30 billion by 2035 (a 5.4% compound annual growth rate), with food and
beverage representing the largest application segment. Fortune Business Insights
estimates the global kava root extract market growing from approximately US$1.87 billion
in 2025 to US$7.40 billion by 2034 (a 16.58% compound annual growth rate), reflecting
increasing global demand for kava-based relaxation and wellness products.¹
Rather than duplicating manufacturing investment, the Partnership combines KAPPL's
advanced processing capability with The Calmer Co.'s established commercial platform,
creating a scalable operating model that enables each organisation to focus on its
respective core strengths while supporting continued innovation, international expansion
and long-term value creation.
The Board believes the Partnership positions The Calmer Co. to continue expanding its
premium botanical ingredients platform while strengthening Fiji's position as a globally
recognised producer of value-added botanical products.
Building an Integrated Premium Botanical Ingredients Platform
A key feature of the Partnership is that it combines The Calmer Co.'s established
commercial platform with KAPPL's investment in advanced manufacturing capability,
enabling each organisation to focus on its respective core strengths.
Under the proposed operating model, The Calmer Co. will continue to control the
procurement and ownership of premium kava raw materials through its established
grower network and supply chain. The Company will also retain ownership and control of
its proprietary formulations, product specifications, internationally recognised brands,
customer relationships, intellectual property and global commercialisation activities.
Doc 1418089494.1 4
KAPPL will provide advanced manufacturing capability by transforming Company-supplied
raw materials into premium botanical ingredients and finished branded consumer
products manufactured to The Calmer Co.'s specifications and quality standards.
The Company believes this structure creates a scalable and capital-efficient operating
model that combines The Calmer Co.'s expertise in sourcing, innovation, branding and
commercialisation with KAPPL's manufacturing capability and investment in advanced
processing technology.
Expanding Advanced Manufacturing Capability
A significant strategic benefit of the Partnership is the addition of advanced botanical
manufacturing capability within Fiji.
KAPPL's new manufacturing facility, expected to be commissioned in December 2026, will
incorporate supercritical CO₂ extraction technology together with expanded manufacturing
and processing infrastructure.
The Calmer Co. currently works with specialist extraction partners in Australia and India to
support its growing premium botanical ingredients business. The commissioning of
KAPPL's facility will provide the Company with additional manufacturing capability within
Fiji, complementing its existing specialist manufacturing partners, locating advanced
extraction capability closer to the Company's premium raw material supply and increasing
production flexibility as international demand continues to grow.
The Company expects the Partnership will:
• expand manufacturing capacity for premium botanical ingredients;
• strengthen supply chain resilience through additional manufacturing capability;
• provide greater production flexibility across multiple manufacturing partners;
• support continued product innovation;
• increase value-added botanical processing within Fiji; and
• support the continued expansion of one of the Company's fastest-growing
commercial businesses.
The Company intends to continue working with its existing specialist extraction partners
while progressively integrating KAPPL's manufacturing capabilities into its broader
manufacturing network as commercial opportunities develop.
Doc 1418089494.1 5
Strategic Partnership Roadmap
The HOA establishes a phased framework designed to progressively expand the
Partnership as key commercial milestones are achieved.
Phase One – Strategic Manufacturing Partnership
The initial phase of the Partnership will, subject to execution of definitive agreements,
focus on establishing the manufacturing relationship and transitioning agreed production
activities to KAPPL's new manufacturing facility.
Key initiatives include:
• relocation of agreed manufacturing equipment to KAPPL's facility;
• long-term equipment lease arrangements;
• manufacture of Fiji Kava®
, Taki Mai®
and Authentic Kava®
branded consumer
products;
• manufacture of premium botanical ingredients and extracts;
• implementation of quality assurance systems and operational governance; and
• commencement of commercial production following commissioning of KAPPL's
advanced manufacturing facility.
Phase Two – Manufacturing Asset Transition
Subject to successful implementation of Phase One and mutual agreement between the
Parties, Phase Two provides a framework to evaluate the long-term transition of
manufacturing assets and further expansion of manufacturing capability.
This phase may include, to the extent agreed:
• acquisition of leased manufacturing equipment by KAPPL;
• expansion of manufacturing capacity;
• operational optimisation;
• additional value-added processing capability; and
• continued investment in advanced botanical manufacturing.
Phase Three – Strategic Integration
Subject to the successful implementation of the earlier phases, future negotiations,
execution of definitive agreements and all required corporate and regulatory approvals,
the HOA provides a framework for the Parties to evaluate broader strategic integration
opportunities.
Doc 1418089494.1 6
These opportunities may include:
• equity participation;
• joint venture arrangements;
• contribution of manufacturing assets;
• integration of agreed Fiji manufacturing operations; and
• other mutually agreed strategic structures that support the long-term objectives of
the Partnership.
Progression beyond Phase One is not automatic. Any future implementation will be subject
to commercial agreement between the Parties, execution of definitive documentation and
all required approvals.
Why the Partnership Matters
The Board believes that the Partnership provides a disciplined and scalable approach to
supporting The Calmer Co.'s long-term growth strategy.
Rather than investing substantial additional capital in manufacturing infrastructure, the
Partnership enables the Company to leverage KAPPL's investment in advanced processing
capability while continuing to focus its capital and management resources on premium raw
material sourcing, innovation, product development, brand building, customer
relationships and international commercialisation.
The Partnership is also expected to strengthen Fiji's position as a producer of premium
value-added botanical products by increasing advanced manufacturing capability within
the country and supporting greater local processing of agricultural products destined for
international markets.
CEO Commentary
Zane Yoshida, Chief Executive Officer of The Calmer Co., commented:
“This Partnership represents one of the most significant strategic initiatives undertaken by
The Calmer Co. in recent years and marks an important milestone in the evolution of our
business.
Over many years, we have invested in building premium brands, securing high-quality raw
material supply, developing proprietary formulations, advancing product innovation and
establishing long-term customer relationships across international markets. Those
investments have created a strong commercial platform and a growing pipeline of
opportunities for premium botanical ingredients and branded consumer products.
Doc 1418089494.1 7
At the same time, Kaiming Agro Processing is making a significant investment in advanced
manufacturing capability, including supercritical CO₂ extraction technology, which aligns
strongly with our long-term strategy.
This Partnership brings together two highly complementary businesses. The Calmer Co.
will continue to control our premium raw material supply, internationally recognised
brands, intellectual property and global customer relationships, while leveraging KAPPL's
advanced manufacturing capability to transform those raw materials into premium
botanical ingredients and finished consumer products. It also allows us to remain focused
on the areas where we create the greatest value - innovation, premium raw material
sourcing, brand development and global commercialisation.
Importantly, this Partnership complements, rather than replaces, our existing specialist
manufacturing relationships and provides additional capability and flexibility as
international demand for premium botanical ingredients continues to grow.
We believe this creates a stronger, more scalable business model that positions The
Calmer Co. for sustainable long-term growth while supporting Fiji's ambition to become a
globally recognised producer of premium botanical ingredients.”
KAPPL Commentary
Calvin Qiu, Managing Director of Kaiming Agro Processing Pte Ltd, commented:
“Since establishing Kaiming Agro Processing in 2005, our vision has been to build one of
the South Pacific's leading botanical processing businesses by combining Fiji's exceptional
agricultural resources with world-class manufacturing capability.
Our investment in advanced manufacturing infrastructure represents the next stage of
that vision.
We see The Calmer Co. as the ideal strategic partner. Their internationally recognised
brands, product innovation and established global customer relationships complement
our manufacturing expertise and create significant opportunities for both organisations.
Together, we believe we can strengthen Fiji's reputation as a producer of premium value-
added botanical products while building a partnership capable of supporting long-term
international growth.”
Next Steps
Following execution of the HOA, the Parties will commence negotiation of the definitive
agreements required to implement Phase One of the Partnership.
Doc 1418089494.1 8
These agreements are expected to include:
• Equipment Lease Agreement;
• Contract Manufacturing Agreement;
• Quality Agreement;
• Minimum Performance Targets;
• Product Specifications;
• Manufacturing Transition Plan; and
• Implementation Governance Framework.
Implementation of Phase One will remain subject to:
• execution of definitive agreements;
• commissioning of KAPPL's advanced manufacturing facility;
• satisfaction of agreed conditions precedent; and
• completion of operational readiness activities.
The Company will continue to update shareholders as material milestones are achieved.
About Kaiming Agro Processing
Kaiming Agro Processing Pte Ltd (“KAPPL”) is one of Fiji's leading producers and exporters
of value-added botanical products.
Founded in 2005 by Managing Director Calvin Qiu, the company has established a strong
international reputation for processing and exporting premium ginger and turmeric
products to customers across Australia, New Zealand, North America, the United Kingdom
and Europe.
KAPPL sources raw materials from a network of more than 700 smallholder farmers across
Fiji, supporting rural agricultural communities while producing high-quality export-grade
botanical products. The company manufactures under its own brands and through
strategic international partnerships, including a long-standing franchise arrangement with
The Ginger People, one of the world's leading ginger brands.
KAPPL is currently investing in a new advanced manufacturing facility in Navua, Fiji,
incorporating supercritical CO₂ extraction capability together with expanded processing
infrastructure. Once commissioned, the facility is expected to significantly enhance Fiji's
capability to manufacture premium botanical ingredients and value-added consumer
products for international markets.
This announcement has been authorised for release by the Board of Directors.
ends
Doc 1418089494.1 9
For further information
Investor & Media Relations
Zane Yoshida
investors@thecalmerco.com
Join us on Investor Hub
About The Calmer Co.
The Calmer Co. International Limited (ASX:CCO) is a fast growing beverage business
leveraging a global opportunity in kava and other natural products that replace alcohol and
support relaxation and sleep.
Our products are delivered to consumers globally through e-commerce channels and blue-
chip retail distribution partners, supported by a reliable farm to shelf supply chain.
The product range includes drinking powders, natural and flavoured kava shots,
concentrates and capsules, sold under the brands Fiji Kava®
, Taki Mai®
and Danodan
Hempworks in markets including USA, Australia, New Zealand, China and the Pacific
Islands.
Forward looking statements
This ASX release includes certain forward-looking statements that are based on
information and assumptions known to date and are subject to various risks and
uncertainties. Actual results, performance or achievements could be significantly different
from those expressed in, or implied by, these forward-looking statements. Such forward-
looking statements are not guarantees of future performance and involve known and
unknown risks, uncertainties and other factors, many of which are beyond the control of
the Company. These factors may cause actual results to differ materially from those
expressed in the statements contained in this announcement.
¹ Source: Future Market Insights, Turmeric Market report; Grand View Research, Ginger Extract Market report; Fortune Business
Insights, Kava Root Extract Market report. This information has been sourced from independent third-party market research
reports and has not been independently verified by the Company. It does not constitute a forecast, projection, estimate or
guarantee of future performance by the Company and should not be relied upon as such.
Share your feedback
Discover